tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Eun Yang, 102 are a BUY (71.83%), 35 are a HOLD (24.65%), 5 are a SELL (3.52%).
Analyst Eun Yang, currently employed at JEFFERIES, carries an average stock price target met ratio of 66% that have a potential upside of 42.87% achieved within 358 days.
Eun Yang’s has documented 274 price targets and ratings displayed on 30 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on GBIO, Generation Bio Co at 16-Dec-2025.
Analyst best performing recommendations are on CNTA (CENTESSA PHARMACEUTICALS PLC ADR).
The best stock recommendation documented was for RIGL (RIGEL PHARMACEUTICALS) at 6/8/2022. The price target of $10 was fulfilled within 9 days with a profit of $2.99 (42.65%) receiving and performance score of 47.39.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 10-Jan-2023
$42
$-2.15 (-4.87%)
$42
3 years 14 days ago
(15-Feb-2023)
0/15 (0%)
$-2.18 (-4.93%)
Buy Since 20-Apr-2018
$42
$-2.15 (-4.87%)
$82
3 years 1 months 18 days ago
(11-Jan-2023)
0/4 (0%)
$-2.1 (-4.76%)
Buy Since 10-Sep-2020
$42
$-2.15 (-4.87%)
$68
3 years 1 months 18 days ago
(11-Jan-2023)
0/3 (0%)
$-2.1 (-4.76%)
Hold Since 11-Jan-2023
$55
3 years 1 months 18 days ago
(11-Jan-2023)
0/1 (0%)
$36.77 (201.70%)
Hold Since 09-Jan-2023
$42
$-2.15 (-4.87%)
$61
3 years 1 months 20 days ago
(09-Jan-2023)
0/2 (0%)
$-1.85 (-4.22%)
Which stock is Eun Yang is most bullish on?
Which stock is Eun Yang is most reserved on?
What Year was the first public recommendation made by Eun Yang?
